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ABSTRACT
SENSITIVITY AND SPECIES SPECIFICITY OF BISULFITE MODIFICATION AND
PYROSEQUENCING TECHNOLOGIES USED TO IDENTIFY TISSUE-SPECIFIC
DNA METHYLATION PATTERNS IN COMMON
BIOFLUIDS FOUND IN CRIME SCENES
by Sitara Christian Shirwani
December 2013
In order to convict the guilty or exonerate the innocent in criminal cases, it is
crucial to reconstruct the crime scene and/or determine the nature of the crime.
Identifying the different biofluids found at a crime scene can help shed light on these
aspects of forensic casework. Recently, DNA methylation has been used as a means of
identifying biological materials, as opposed to conventional protein/enzyme based
methods. DNA methylation is the addition of a methyl group to the 5' carbon on a
cytosine base (C), which is directly followed by a guanine base (G) and are called CpG
sites. The "p" in the CpG stands for the phosphodiester bond which connects the two
bases. The study of tissue-specific DNA methylation can serve as a means of identifying
the source of a biofluid. Recently, it has been observed that epigenetic DNA methylation
patterns are specific for individual tissues, suggesting tissue specific differential
methylation patterns. This study was undertaken to determine the sensitivity of the tests
used to study the methylation pattern. Three markers, namely USP49, DDX4, and
DACTl that have already been successful in differentiating sperm from other biological
materials, were chosen to test the sensitivity of these technologies. The DNA quantities
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of 50, 10, 5, 1, 0.5, and 0.1 nanograms were used for the sensitivity study. It is also
important to determine whether the markers chosen to test the sensitivity of these
technologies are human specific, or if the primers will cross react with non-human
biological materials. Therefore, the three previously mentioned markers were studied for
their species specificity. After bisulfite modification, PCR amplification, and
pyrosequencing, it was concluded that these three markers were sensitive enougn for .
forensic casework in varying degrees. The USP49 and DDX4 marker produced adequate
sequencing profiles from at least five nanograms of DNA, without a second round of
amplification. A second round of amplification produced readable results with samples as
low as 0.1 to 0.5 nanograms in DNA quantity. The DACTl marker produced
interpretable profiles with quantities as low as 0.1 to 0.5 nanograms without a second
round of amplification. It was also observed that the human specific primers for each
marker amplified some non-human samples, when tested against cat, dog, goat, cow,
chicken, macaque, chimpanzee, and Erythrobacter and Pseydomonas bacterial samples.
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CHAPTER!
INTRODUCTION
The identification of various biological materials found at a crime scene can
provide crucial information regarding the nature of the crime and crime scene
reconstruction. Some common biological materials found at crime scenes are blood,
semen, saliva, skin, hair, and vaginal epithelial cells. These biological materials can be
used as evidence to convict the guilty or exonerate the innocent in criminal cases.
Forensic evidence submitted to the serology laboratory is analyzed using conventional
serological methods such as presumptive, confirmatory and species specific tests.
Currently, the conventional chemical, serological/immunological, and
microscopic means of identifying biological material can be mainly presumptive and vary
on their degrees of sensitivity and specificity. Also, the protein-based enzymes and
immunological assays that are tested are more susceptible to degradation by
environmental conditions than Deoxyribonucleic acid (DNA). Also, most of these
protein/enzyme assays are incompatible with one another, so they cannot be multiplexed,
therefore, less likely to be automated. Less automation means user-dependant results and
can lead to more operator introduced errors.
An example of blood identification relies on peroxidase-like activity of heme
group of hemoglobin in blood. Some tests to detect blood include the commercial kit
Bluestar®, oxidation-reduction reaction of the Kastle-Meyer phenolphthalein test, and the
chemiluminescence of luminol. All three of the formerly mentioned tests are presumptive
in nature. The detection of saliva mainly depends upon the enzymatic activities of
amylase found in saliva; the commercial kit for amylase is the Phadebas® test (Li, 2008).
Amylase can also be found in other biological fluids such as urine, serum, and in some
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bacteria and plants, so this is not necessarily sensitive or specific to saliva. Semen
identification includes identifying sperm via microscope as the most confirmatory means.
Other testing methods include testing for prostatic acid phosphatase (AP) and/or prostatespecific antigen (PSA). The ABAcard p30 test is a commercial test kit used to identify
the PSA (Abacus Diagnostics, Inc., 2006). The downfall to these protein-based assays is
that proteins are less stable than DNA. A low quantity or quality of proteins within a
sample may cause a negative result in the testing. These tests rely on the functionality of
the proteins to react with its chemical reagents; therefore, proteins that have been
degraded or are no longer intact may hinder the positive/negative outcomes of the test.
This shows that the sensitivity of the tests depend on the quantity and integrity of the
protein being tested. Also, these tests can sometimes cross react with other tissues or
species which lowers the specificity of the tests. For example, the ABAcard®
Hematrace®, one step human hemoglobin test manufactured by Abacus Diagnostics, Inc,
was found to cross react with ferret blood samples (Abacus Diagnostics, Inc., 2005).
This was due to the similarity of certain amino acid sequence of the alpha chain
hemoglobin molecule of humans and ferrets. Also, these types of tests do not allow for
quantitation of sample, but simply detect the presence or absence of a particular
substance. The use of these tests may also consume any DNA present within the sample,
which may already be limited in quantity. If any DNA is unnecessarily consumed during
serological tissue identification, you have less to work with when trying to establish an
identification profile for an individual. Due to the disadvantages listed previously, recent
epigenetic research has led forensic scientists to look further into the use of tissuespecific DNA methylation patterns to differentiate between biological materials
commonly found at crime scenes (Madi, Balamurugan, Bombardi, Duncan, & McCord,
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2012). The amount of DNA present within a sample may not necessarily cause a
negative test result, as with the protein based assays, if DNA is used as a means of
identifying tissues.
A recent alternative approach to biofluid identification has been proposed for the
analysis of tissue-specific species of messenger RNA (mRNA), and micro RNA
(miRNA) (Frumkin, Wasserstrom, Budowle, & Davidson, 2011). The differential
expression of genes in different tissues causes different levels of these mRNAs and
miRNAs. The level of expression of mRNA or miRNA can be indicative of the tissue
source. However, RNA is also less stable than DNA thereby reducing the chances of
being detected if the samples had been through adverse environmental conditions. Along
with being less stable than DNA, another downfall of RNA analysis is consumption of
sample. Unless it is co-extracted along with DNA, the use of RNA technologies can
reduce the amount of already limited DNA sample. Two more recent alternative
approaches proposed are fluorescence and Raman spectroscopy (Virkler & Lednev,
2009). These approaches allow for the potential of on-scene and non-destructive analysis
for tissue identification. Even though these are state of the art techniques, the
disadvantages of these approaches are cross reaction with the biofluids of other species,
or non-biological materials within the sample. Also, since forensic biologists are
acclimated to handling DNA, as opposed to RNA, it would be more beneficial to create a
DNA-based assay for body fluid identification along with human identification. The
epigenetic DNA methylation profiles may be the answer to these tissue identification
dilemmas.
Epigenetic modifications, such as DNA methylation or histone deacetylation,
occur as a cell develops and matures into a specialized cell (Madi et al., 2012). These
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modifications take great part in regulating the gene expression of that specific cell and
dictates structure and function of a cell at specific times of a cells ' life. Epigenetics can
be referred to as "a heritable change in the pattern of gene expression that is mediated by
mechanisms other than alterations in the primary nucleotide sequence of a gene"
(Herman & Baylin, 2003, p. 2042). DNA methylation is the most stable type of
epigenetic modification within the mammalian genome (Eckhardt et al., 2006).
Methylation occurs on the 5' carbon of the cytosine (C) pyridine ring. This methylation
occurs on cytosine bases that are immediately followed by guanine (G) bases, thus they
are called CpG sites. The 'p' in the CpG refers to the phosphodiester bond between the
'C' and the 'G' located in the same strand.
Several epigenetic markers have been identified to detect the presence of a
particular biofluid in forensic samples (Frumkin et al., 2011; Madi et al., 2012). It has
been determined that the three genetic loci, USP49, DACTl , and DDX4 were found to be
successful in differentiating sperm from other biofluids such as blood, saliva, skin cells
and vaginal epithelial cells (Balamurugan, 2013). Other studies have also shown that
these markers can differentiate sperm from other biofluids (Kitamura et al., 2006; Lee et
al., 2011). These three markers show hypomethylation for sperm samples, and
hypermethylation in other biological samples.
Even though these works seem to be very promising, most of the samples
analyzed were available in abundant quantities. This may not be the case in a forensic
case work and the quantity of the samples available may be limited or degraded. Also, it
is very important to establish that the primer sets that are used to amplify the epigenetic
markers are human specific. In order to determine the sensitivity and the least amount of
sample required for tissue identification using epigenetic markers, and species specific
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amplification, I undertook this research to determine (a) the sensitivity of the epigenetic
markers for biofluid identification and (b) the species specificity of the markers. Three
tissue types, blood, sperm, and saliva collected from volunteers were used to test the
sensitivity of the three epigenetic markers, namely USP49, DACTl , and DDX4. The first
step ofthis project is to determine the most beneficial amount of DNA to go into bisulfite
conversion that can be used to obtain readable results in a pyromark methylation assay.
Secondly, DNA from different species was tested to define the species specificity of the
three markers tested. The standard methylation assay depends on the bisulfite conversion
of the DNA samples followed by polymerase chain reaction (PCR) and pyrosequencing
that determines the percent methylation of each CpG site. During the bisulfite
modification, all unmethylated ' C' residues are converted into uracil (U), and
subsequently converted to thymine (T) during PCR. In a CpG site, if the ' C' is
methylated they are resistant to conversion and will not be converted to 'U'. After the
bisulfite modification, the newly converted DNA are amplified by PCR using a primer
set, in which one primer is biotin labeled. The modified biotinylated PCR products are
then sequenced to determine the relative methylation in the samples. The results of this
study are used to determine the least amount of DNA that can be used for bisulfite
conversion and subsequently to determine the methylation percentage of different CpG
sites. Lastly, it can also be determined that if the pyromark CpG assays are human
specific or cross react with other non human samples.
Aims and Objectives
The aim of this research is (1) to determine the sensitivity of the Pyromark assay
when samples are tested for the tissue specific differential methylation pattern, and (2) to
determine the species specificity of the methylation assay. The three markers, USP49,
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DACTl , and DDX4 are found to have tissue specific methylation patterns and are
considered markers for sperm identification. The sensitivity of the assay for these three
markers was determined in this study using different DNA quantities. Also, the primers
used to amplify the above three markers are considered human specific, but there has
been no study reported regarding the human specificity. So, a set of non human D_N A
samples were used to determine the species specificity of the three listed markers.
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CHAPTER II
REVIEW OF LITERATURE
Previous studies related to epigenetic research are aimed toward identifying and
mapping DNA methylation and histone modifications. The "DNA methylation profiling
of human chromosomes 6, 20 and 22" study lists many epigenomic projects that will be
integrated to "identify, catalog and interpret genome-wide DNA methylation profiles of
all human genes in all major tissues" (Eckhardt et al., 2006, p. 1378). This study also
states that an estimation of 80% of all CpG sites are methylated within mammals. Their
study focused on human chromosomes 6, 20, and 22 and identified 1.9 million CpG
methylation values from 12 different tissues. They reported that "evolutionarily
conserved regions are the predominant sites for differential DNA methylation" within six
annotation core regions amongst transcriptional start sites (Eckhardt et al., 2006, p.
1378). Their analysis focused on 43 different samples including sperm, dermal
fibroblasts, dermal keratinocytes, dermal melanocytes, and CD4+ and CD8+ lymphocytes,
heart tissue, muscle tissue, skeletal muscle tissue, liver tissue and placenta. These
samples contained a control for two parameters: age and sex, which has the potential to
cause a different DNA methylation pattern. Their study generated a DNA methylation
reference map important to unlock the human epigenome. This also provides insightful
information pertaining to chromatin which is functionally crucial to the human genome.
This type of research will also be invaluable to drug efficacy monitoring and diagnostics.
Another benefit of understanding the epigenome is the epigenetic approach to
understanding common diseases and cancers. The method used for their research was
bisulfite conversion and PCR sequencing which allowed for quantitation of methylation
at a given CpG site with high reproducibility and accuracy. Modification of the sample
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DNA by sodium bisulfite conversion is necessary because methylation is lost during the
PCR process. Treating the DNA with the sodium bisulfite converts unmethylated
cytosine bases to uracil. Bisulfite is more selective to cytosine bases because of the
presumption of less steric hinderance when compared to a 5-met-cytosine (Applied
Biosystems, 2007). The bisulfite deaminates the cytosine, thus converting it to a uracil
(Figure 1). Subsequent PCR process will further convert the uracils to thymines.
Detection of the changes in bases can be done by a variety of sequencing methods.
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Figure 1. Chemical scheme for the conversion of cytosine to uracil. Cytosine reacts with
bisulfite, but 5-Me-cytsoine does not react (Applied Biosystems, 2007).

Another study by Harrison and Parle-McDermott (2011) provided a time line of
methods and approaches to DNA methylation. This starts with the Human Genome
Project beginning in 2003 and the realization that this was only the start of elucidating
what all is involved in the genetic world. DNA methylation was first found to influence
gene expression in 1975 by studying bacteria. Holliday and Pugh were credited by first
suggesting that "it may be significant that doublet CpG is most highly methylated" in
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their DNA methylation model for eukaryotes. (Harrison & Parle-McDermott, 2011). This
review paper explains how DNA methylation is an important molecular mechanism in
many biological processes such as genomic imprinting, X-inactivation, and tissue specific
gene expression. Some early methods used to analyze DNA methylation patterns were
High Performance Liquid Chromatography (HPLC), and Thin-Layer Chromatography
(TLC), in approximately 1980 (Harrison & Parle-McDermott, 2011). HPLC is based on
the quantitative hydrolysis of DNA using DNase I and nuclease Pl, followed by
treatment with alkaline phosphatase. The individual bases can then be monitored based
on their UV absorbances at 254 and 280 nm. The HPLC and TLC methods were only
"capable of measuring the relative ratio of methylated cytosine residues against
unmethylated cytosines" (Harrison & Parle-McDermott, 2011, p. 2). This is useful when
comparing different plant and animal species. Some earlier methodologies were
radiolabeling which measure the level of radioactivity against the level of DNA
methylation of a sample. Anti-methylcytosine was an immunological DNA methylation
assay which utilized specific antibodies in 1985. Methylation-sensitive restriction
enzymes were identified in the late 1970s, as being able to " cleave DNA through
recognition of specific nucleotide motifs" (Harrison & Parle-McDermott, 2011, p. 3). The
"sodium bisulfite era" occurred in 1970, which recognized that treating DNA with
sodium bisulfite will deaminate cytosine residues into uracil .. .which made it possible to
change a chemical modification of DNA to an easily detected genetic element. Later, in
the 1990s, microarray technologies were developed which allowed for "high-throughput
analysis of single nucleotide polymorphisms and other genomic variants" (Harrison &
Parle-McDermott, 2011, p. 5). In 2002, methylation-specific oligonucleotide arrays
allowed for bisulfite modification and PCR amplification to convert unmethylated
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cytosines to thymine. This allowed for epigenetic modifications to be detected by
conventional hybridization methods. Eventually sequencing methods such as Sanger
sequencing, whole genome sequencing, and methyl-sensitive restriction enzyme
sequencing allowed for more automated and high-throughput advancements in epigenetic
research. These advancements in methodologies for genome and epigenome studies will
allow for vital information to be uncovered and at a progressively decreasing cost.
Kitamura et al. (2006) studied 150 tissue-specific differentially methylated
regions, (tDMR) from six mouse tissues by restriction landmark genomic scanning.
Fourteen of these tissues were further studied along with their DNA sequences. Six of
these regions are homologous to both humans and mice. Genes in five of these regions
have conserved tissue-specific expression: preferential expression in testis. DDX4 is one
of the tDMRs and is further analyzed in nine testis tissues. After analysis, this marker
showed increased methylation in the promoter region that is significantly linked to a
reduction in gene expression and spermatogensis defects. Kitamura et al. knew the
previous information suggested that "hypomethylation of the DDX4 promoter region
regulates DDX4 gene expression in spermatogenic cells" (Kitamura et al., 2006, p. 326).
Their study was indicative of some mouse and human genomic regions with tDMRs and
expression were conserved, along with the suggestion that "DNA methylation may have
an important role in regulating differentiation and tissue-/cell-specific gene expression of
some genes" (Kitamura et al., 2006, p. 326). This study identified the DDX4 marker as
being hypomethylated in the promoter region which regulates DDX4 gene expression
within spermatogenic cells making this marker a hopeful candidate to become a
sperm/seminal fluid identifying marker. This marker was tested in our lab and was
determined to be a successful sperm marker (Balamurugan, 2013).
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There are several oncology research projects which study the link between
methylation in promoter regions of CpG islands and cancer development and progression.
Testing for methylation of CpGs in tissue DNA has become an informative tool for
"tumor detection, outcome prediction, and treatment selection, as well as for assessing
the efficacy of treatment with the use of demethylating agents and monitoring for tumor
recurrence" (Sepulveda et al. , 2009, p. 266). This report stated unmethylated CpG sites
within CpG islands of promoter regions are actively transcribed genes, while island CpG
sites with increased methylation are associated with reduction in gene expression and
possible gene silencing (Sepulveda et al., 2009). This study speaks on several methods
used in CpG methylation testing, one involving bisulfite conversion. They explain how
majority of testing start with the conversion of unmethylated CpG cytosine to uracil
(subsequently converted to thymine via PCR amplification). Methylated cytosines are not
converted to uracil. The newly converted sequences can be detected by several
techniques and then compared to the known sequence in question. This study lists the
disadvantages of bisulfite conversion such as degradation of DNA of "up to 85% to 95%"
(Sepulveda et al., 2009, p. 267). This study also lists pyrosequencing as a method of
qualitative and quantitative CpG methylation detection after bisulfite conversion. A
method which does not use bisulfite conversion is the use of methylation-sensitive
restriction enzymes which has been mentioned from a previous study reviewed. This
method uses methylation-sensitive restriction endonucleases which can discriminate
between methylated and unmethylated CpG sites (Sepulveda et al., 2009), followed by
PCR for detection of CpG methylation. This technique does not degrade DNA and also
makes "down-stream analysis relatively simple". Some disadvantages of this technique
are that there is a limited amount of discriminatory restriction enzymes for certain
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fragments of interest, incomplete digestion can occur which will produce false-positive
results of methylated sites, and also all or none readouts that do not depend on the
number of accessible restriction sites within the fragment, producing identical results
regardless of whether one or all sites are unmethylated (Sepulveda et al. , 2009).
Herman and Baylin (2003) study the role of epigenetic changes in relation to
cancer development. They define the term of epigenetics as "a heritable change in the
pattern of gene expression that is mediated by mechanisms other than alterations in the
primary nucleotide sequence of a gene" (p. 2042). Essentially, this means there is no
change in the sequence of one's DNA, but more like changes in chemical structure of a
base on the DNA. Transcription of DNA into RNA begins in the promoter regions of a
gene. If the promoter region becomes methylated, it can change the expression of that
gene, even silencing it. For example, if methylation occurs in a tumor-suppressor gene,
that gene will be silenced and no longer able to suppress the growth of tumors. The
overall frequency of CpGs in the genome is substantially less than what would be
mathematically predicted, probably because DNA methylation has progressively depleted
the genome of CpG dinucleotides over the course of time (Herman & Baylin, 2003). This
depletion occurs because methylated cytosines have the potential to deaminate, creating
thymidine. When these mutations are not repaired, the thyrnidine remains, instead of the
original cytosine base (Herman & Baylin, 2003). This study explains how DNA
methylation may hold the large noncoding areas of DNA in an inactive state. These areas
contain elements such as small stretches of repeats, inserted viral sequences, and
transposons that could potentially harm cells. This is a type of maintenance for genes.
Almost half the genes in our genome have such CpG-rich promoter regions. In the bulk
of the genome, about 80% of the CpG dinucleotides that are not associated with CpG
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islands are heavily methylated. In contrast, the dinucleotides in CpG islands, especially
those associated with gene promoters, are usually unmethylated, whether or not the gene
is being transcribed (Herman & Baylin, 2003). All types of cancers have been examined
and they have shown that "both loss of methylation in the CpG-depleted regions where
most CpG dinucleotides should be methylated and gains in methylation of CpG islands in
gene promoter regions" cause mass confusion (Herman & Baylin, 2003, p. 2044). The
loss of methylation for tumorigenesis can fust cause "weakening of transcriptional
repression in normally silent regions of the genome which could cause the potentially
harmful expression of inserted viral genes and repeat elements and of normally silenced
genes, such as imprinted genes and genes on the inactive X chromosome" (Herman &
Baylin, 2003, p. 2044). A second consequence ofloss of methylation could affect
structural and functional stability of chromosomes. The gain of DNA methylation in gene
promoter regions could cause transcription silencing and inactivation of tumor-suppressor
genes, along with mutations. According to Baylin, Futscher, and Gore (2004), "promoter
methylation may occur at least as often as such mutational changes as the cause of loss of
gene function in known tumor-related genes" (p. 3). Enzymatic proteins that mediate
DNA methylation are called DNMTl, DNMT3a, and DNMT3b. These are active in
mammalian cells. Epigenetic silencing is thought to be reversible, while genetic
mutations are irreversible. Demethylating agents are being studied clinically in hopes to
treat or prevent cancerous conditions. Also, inhibitors ofDNMTs have demethylation and
antitumor effects in an experimental setting. Baylin et al. (2004) states, "as understanding
of these epigenetic mechanisms improves, it should be possible to significantly improve
current approaches to cancer prevention and therapy" (p. 6). Baylin et al. (2004) also
explains, "the human genome contains approximately 25,000 to 40,000 genes with
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anywhere from 12,000 to 20,000 of these genes being active at a given time in any given
cell" (p. l 0). The oncogenic-related genes are now being compiled into a list, along with
the number of tumor-suppressor genes and DNA repair and metastasis inhibition (Baylin
et al., 2004).
Frumkin et al. (2011) and Lee et al. (2011) both based their studies on a forensic
approach to use DNA methylation for tissue identification. Frumkin et al. reiterates how
conventional serological methods of identifying tissues "are applicable only to a subset of
samples, might suffer limitations such as low specificity, lack of sensitivity, and are
substantially impacted by environmental insults" (p. 517). They also explain how these
assays cannot be multiplexed due to incompatibility, and less prone to automation so
more operator induced errors can be made. The study explains messenger RNA and
micro RNA approach, but, also, how RNA is more susceptible to environmental
conditions than DNA. They studied DNA-based assays for tissue identification based on
"tissue-specific methylation patterns" (Frumkin et al., 2011 , p. 517). Methylationsensitive restriction enzyme assay was the technique used for their study. Once the
samples were treated with the enzymes, subsequently fluorescent-labeled primers were
added and subjected to multiplex amplification. Capillary electrophoresis and automatic
signal analysis software detected these labeled, amplified products, and thus determining
the tissue. This method allows for full automation, operator-independent results,
multiplex reactions, and the ability to combine tissue identification with DNA profiling in
a single procedure. This assay was tested on 50 DNA samples from blood, saliva, semen,
and skin epidermis, and the source tissue was successfully identified in all cases. The
assay correctly detected semen in all samples where it was present, and the calculated
percentage of semen was comparable to the fraction of semen in the samples (Frumkin et
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al., 2011). Lee et al. (2011) used bisulfite treatments, PCR amplification of the target
marker, cloning of the PCR products, and subsequent sequencing of the cloned fragments
using fluorescent sequencing. The DNA sequences were then aligned against "in silicoconverted genomic reference sequences using BiQ Analyzer" (Lee et al. , 2011, p. 2). Five
tissue-specific differentially methylated regions within the genes DACTl, USP49,
HOXA4, PFN3, and PRMT2 were analyzed. The regions chosen from DACTl and
USP49 were showing "semen-specific hypomethylation, and the tDMRs for HOXA4,
PFN3, and PRMT2 displayed varying degrees of methylation according to the type of
body fluid" (Lee et al., 2011, p. 1). This study showed that USP49 and DACTl could be
used successfully to identify semen samples including sperm cells. Research by Madi et
al. (2012) successfully identified ZC3H12D and FGF7 loci to be differentially methylated
specific to sperm when compared to blood, saliva and epithelial cells. They also found
that C20orfl 17 locus differentiated blood from saliva, sperm, and epithelial cells. It was
also determined that BCAS4 locus can differentiate saliva from blood, sperm, and
epithelial cells.
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CHAPTER III
MATERIALS AND METHODS
Sample Collection
Human samples
Three tissue types, blood, saliva, and semen, were collected from volunteers.
Buccal swabbing was performed to collect saliva and cells from the inside of volunteers'
cheeks, with a sterile cotton-tipped swab. The participant performed this collection in
presence of the researcher and the sample was returned.to the researcher. The blood
samples were collected using a disposable lancet device. The researcher swabbed the
participant's finger with an alcohol pad before pricking the finger with the lancet. Blood
samples were collected on sterile cotton-tipped swabs, by the researcher. After collection,
the finger was, again, swabbed with an alcohol pad. Male volunteers willing to provide a
semen sample were asked to collect the sample in a way most private and convenient to
them. A specimen cup was provided to the volunteer in which to collect the sample. The
male participant was instructed to freeze the sample if arrangements for getting the
sample to the principal investigator are not within a period of eight hours, but freezing is
not absolutely necessary if the participant is unable to do so. Depending on the
participant's wishes, the participant was allowed to bring the sample to the investigator or
the principal investigator made arrangements to pick the sample up from the volunteer.
All samples were assigned identification numbers upon collection, to keep the samples
confidential.
Non-Human samples
Blood was collected from domestic pets, such as cat and dog, by a local veterinary
clinic, by trained professionals during their routine veterinary procedures. Blood samples
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were obtained from the domestic animals by the veterinarian in sterile blood collection
vials. The cow, chicken, and goat tissue or blood samples were purchased from local
butchers or supermarkets. Bacterial samples were obtained from the Biological Sciences
research laboratory at University of Southern Mississippi, Hattiesburg campus. The
primate samples are available in the DNA research laboratory, School of Criminal
Justice, University of Southern Mississippi, Hattiesburg campus.
Sample Extraction and Modification
The DNA was extracted from all samples using standard organic extraction
protocols and/or commercial columns. They were then concentrated using Amicon Ultra
centrifugal filter units (Millipore Corporation, Bedford, MA). Any residual organic
chemicals were removed from the samples by washing the sample, up to four times, in
the filter units with Tris-EDTA (TE) buffer. The samples were then collected, measured,
and placed into new 1.5 ml tubes for storage until ready for analysis. The extracted
human DNA samples were quantitated using Quantifiler human DNA quantitation kit and
real-time PCR instrument model 7500 (Applied Biosystems, Foster City, CA). All
human DNA samples were diluted to 0.1, 0.5, 1, 5, 10, and 50 nanogram (ng) quantities
and used for bisulfite conversion using the EpiTect® Bisulfite Kit (Qiagen Inc, Valencia,
CA). All converted human DNA samples were amplified using locus specific primers.
The amplified fragments were analyzed using a Pyromark Q24 pyrosequencer to
determine the methylation pattern, peak height, and sequence comparison. All nonhuman DNA samples were run on an agarose gel to determine the approximate DNA
quantities. Once the quantities are determined, approximately 60-500 ng of non-human
DNA were bisulfite modified and PCR amplified for the respective markers and the DNA
sequence was determined using pyrosequencing.
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Loci Selection and Assay Design
USP49 and DACTl loci were reported in a previous study to have specific
methylation patterns for sperm samples. The DACTl marker was found to be
"unmethylated in 93% of the clones from sperm but hypermethylated in all of the clones
from blood, saliva, menstrual blood, and vaginal fluid" (Lee et al., 2011, p. 4). The
USP49 marker was found to be "hypomethylated in 97% of clones from sperm, while

..

almost all of the clones from the other body fluids were hypermethylated" (Lee et al.,
2011, p. 4). The study by Kitamura et al. (2006) found that the DDX4 gene, containing
hPst3 loci associated with testis-specific expression, is hypomethylated in CpG sites
within the promoter region. The sensitivity of the assays for all three markers is
addressed in the current study.
Custom designed PyroMark® CpG assays and primers used in this study were
obtained from Qiagen Inc, Valencia, CA. These assays contain the region containing the
CpG sites. DACTl locus contains six CpG sites, while the USP49 and DDX4 loci contain
nine CpG sites each.
Template Preparation for Pyrosequencing
All samples underwent amplification at all three markers: USP49, DACTl , and
DDX4. 2.5 microliters (µl) of modified DNA was added to the reagents of the Qiagen
Pyromark® PCR kit, which includes the individual 1x PCR primers (pertaining to the
appropriate assay), lx PCR master mix, lx CoralLoad concentrate, and lx Q solution for
a total volume of 25 µl. The PCR primer set contains a forward and reverse primer, one
of which is biotin-labeled. The reactions were gently vortexed, centrifuged, and placed in
the GeneAmp® PCR System 9700 thermalcycler (Applied Biosystems, Foster City, CA)
and were subjected to thermal cycling with an initial incubation step of 95° C for 15
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minutes, followed by denaturation at 94°C for 30 seconds, annealing for 30 seconds with
varying temperatures depending on the assay (56°C for USP49, 54° C for DACTl, and
51 °C for DDX4), and primer extension at 72°C for 30 seconds with a final extension step
of 72°C for 10 minutes. All samples were subjected to 45 cycles of thermal cycling and
the reactions were held at 4°C until removed from the thermal cycler. After the PCR
process, the samples were analyzed in a 2% agarose gel to determine the efficiency of
amplification. If the samples did not show a sufficient amount of amplified DNA, the
samples were diluted according to their intensities and subjected to a second round of
PCR. The nested PCR process had the same requirements for thermal cycling and reagent
mix as the first PCR. For the species specificity determination, DNA samples from nonhuman sources were analyzed. They were extracted using the same method as the human
samples. Approximately 60-500 ng of the non-human DNA samples were bisulfite
modified using Epitect bisulfite kit (Qiagen, Inc.) and amplified using the human specific
primers for the same three markers and the amplicons were analyzed using a 2% agarose
gel for the robustness of amplification. All amplified products were pyrosequenced using
the Q24 pyrosequencer protocol to compare with the human samples.
Pyrosequencing
The PyroMark Q24 Pyrosequencer and assay software were used for
pyrosequencing of the samples. The sequencing primers and assays were custom
designed based on information found in previous studies. Approximately 0.5-2
picomoles ofbiotinylated PCR products (approximately 100-200ng) were immobilized to
Streptavidin-coated Sepharose high-performance beads (GE Healthcare,
Buckinghamshire, UK) according to the PyroMark Q24 manufacturer's recommendations
(Qiagen, Inc.). The immobilized PCR products were then captured using the PyroMark
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Q24 vacuum workstation and then washed with 50 milliliters (mL) of 70% ethanol for
five seconds, denatured with 40 mL of PyroMark denaturation solution for five seconds,
and neutralized with 50 mL of PyroMark wash buffer for 10 seconds. The biotinylated
single stranded PCR products were then released into a 24-well format PyroMark Q24
plate containing 25µL of tx sequencing primer (0.3µM) diluted in PyroMark annealing
buffer. Annealing of the sequencing primer to the single-stranded DNA were performed
by incubating the plates on a pre-warmed heat block at 80°C for two minutes followed by
incubation at room temperature for 10 minutes. After annealing, the plates were loaded
into the PyroMark Q24 instrument. Appropriate amounts of enzyme, substrate, and
dNTPs were loaded in the instrument prior to sequencing. Following the sequencing
reaction, the data collected were analyzed using the PyroMark Q24 software for CpG
methylation quantitation and the corresponding percent methylation values for each CpG
site and sequence data were displayed as a pyrogram.
Inside the PyroMark Pyrosequencer, the hybridized products are incubated with
the enzymes, substrates, DNA polymerase, adenosine triphosphate (ATP) sulfurylase,
luciferase, apyrase, adenosine 5' phosphosulfate (APS), and luciferin. When the
complementary nucleotides are being released for incorporation to the new strands, it is
accompanied by the release of pyrophosphate in a quantity equimolar to the amount of
incorporated nucleotide. ATP sulfurylase converts pyrophosphate to ATP in the presence
of adenosine 5' phosphosulfate (APS). This ATP drives the luciferase-mediated
conversion of luciferin to oxyluciferin that generates visible light in amounts that are
proportional to the amount of ATP. The light produced in the luciferase-catalyzed
reaction is detected by a charge coupled device (CCD) chip and seen as a peak in the raw
data output (Pyrogram). The height of each peak (light signal) is proportional to the
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number of nucleotides incorporated (Qiagen, 2012). The apyrase degrades any unused
deoxribonucleotide triphosphates (dNTPs) and ATP, allowing for the next nucleotide to
be added. The nucleotide sequence continues to grow and the software detects the visible
light and thus interpreting it into peaks. The peaks displayed on the pyrogram are
analyzed by the PyroMark Q24 software which quantitates the percent methylation at
each CpG site. Reagent blanks and negative controls are also used in the experiment to
insure proper chemical reactions/instrument functioning and any DNA contamination of
reagents. There are also controls placed into the assays which dispense a nucleotide not
part of the target sequence that should not show any reaction. These are placed at the
beginning of the sequence and at approximately one for every CpG site. The resulting
pyrograms were analyzed manually for the sample peak heights and sensitivity of the
different dilutions of DNA samples for each marker.
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CHAPTERIV
RESULTS
Sensitivity Study
All DNA samples were extracted, quantitated, and then diluted to 50, 10, 5, 1, 0.5,
and 0.1 ng quantities. All dilutions underwent bisulfite conversion. After conversion,
each set of dilutions were amplified with primers specific for all the three markers for the
three tissue types. After each marker was amplified, the samples were run through a 2%
agarose gel to check the robustness of amplification. The intensity of the bands in the gel
is indicative of how well the sample will run during pyrosequencing.

DDX4Marker
The amplified PCR products for the marker DDX4 was run on a 2% agarose gel
and the data are shown in Figures 2a and 2b.
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Figure 2a. Image of a 2% agarose gel showing the PCR products of all dilutions of sperm
DNA for the DDX4 marker from the first amplification. Figure 2b. PCR products of all
dilutions of sperm DNA for the DDX4 marker from the nested PCR amplification.
L= lOObp ladder; N=negative control; number above each lane represents DNA quantity
(ng).
As indicated in the gel (Figure 2a), the only two strong bands are from 50 and 10 ng
during the first round of amplification. On the contrary, the second round of amplification
using the first round of PCR product as template provided strong bands for all dilutions,
including the 0.1 ng (Figure 2b). To determine the sensitivity of the assay, a peak height
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of approximately 20 arbitrary light units was used to consider a pyrogram as having
sufficient information. For the DDX4 marker, all the dilutions were amplified and
sequenced. Only the 5 ng of DNA provided a readable sequence from the first round of
PCR while good sequence was obtained from all the dilutions of the nested PCR
including the least DNA quantity of O.lng (Figure 3a, 3b; Table 1).
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Figure 3a. Partial sequence pyrogram on the left showing data from 5 ng of DNA from
blood for the DDX4 marker from the frrst amplification. Figure 3b. Partial sequence
pyrogram on the right showing the data from the nested PCR amplified sample of 0.1 ng
of DNA.
Table 1

DDX4 Sensitivity composite data

5 ng

1 ng

0.5 ng

0.1 ng

"V

"V

"V

"V

"V

"V

"V

"V

NA

NA

NA

NA

NA

NA

"V

"V

"V

Sample

50 ng

10 ng

Sperm I PCR

...J

"V

IIPCR

"V

Blood I PCR
IIPCR
Buccal I PCR

"V
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Table 1 (continued).

Sample

II PCR

Note.

50 ng

lOng

5 ng

1 ng

0.5 ng

0.1 ng

NA

NA

NA

NA

NA

NA

'V = indicates the concentration that gave a readable pyrogram.

NA= not analyzed.

Table 1 shows the first round of PCR resulted in 5 ng being the lowest quantity that
provided sufficient information, while the second PCR resulted in 0.1 ng providing
sufficient information.

USP49 Marker
All the DNA dilutions for the three tissue types were amplified for the USP49
marker and the robustness was checked on a 2% agarose gel. Figure 4a and 4b show the
first and nested PCR amplification products. As noted on the gel in the first PCR round
the band intensities are stronger up to the 5ng level whereas on the nested PCR round the
band intensities are stronger at the 0.1 ng level (Figure 4a and 4b).
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Figure 4a. Image of a 2% agarose gel showing the PCR products of all dilutions of
buccal DNA for the USP49 marker from the first amplification. Figure 4b. Agarose gel
image showing PCR products of all dilutions of sperm DNA for USP49 marker from the
nested amplification.. L= lOObp ladder; N=negative control; number above each lane
represents DNA quantity (ng).
For the USP49 marker all the three tissue types were analyzed, each sample with six
dilutions as described on the materials section. Interpretable data was observed in the
pyrogram from dilutions ranging from 5 to 10 nanograms of DNA from the first round of
amplification. Dilutions below 5 ng did not yield any interpretable data. So, all the
amplicons from the first PCR were reamplified and sequenced to see if the sensitivity
could be improved. The second amplification yielded a significant improvement in peak
heights. Interpretable results were obtained from dilutions of 0.1 ng to 0.5 ng of template
DNA (Figure 5a, 5b; Table 2).
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Figure 5a. Partial sequence pyrogram on the left showing data from 5 ng of DNA from
buccal cells for the USP 49 marker. Figure 5b. Partial sequence pyrogram on the right
showing the data from the nested PCR amplified sample of 0.1 ng of sperm DNA.
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Table 2
USP49 Sensitivity composite data

Sample

50 ng

Sperm I PCR

....J

IIPCR

....J

....J

Blood I PCR

....J

....J

IIPCR

....J

....J

....J

Buccal I PCR

....J

....J

....J

IIPCR

....J

....J

....J

10 ng

5 ng

1 ng

0.5 ng

0.1 ng

Note . ....J = indicates the concentration that gave a readable pyrogram. NA= not analyzed.
The sensitivity results composite table for USP 49 marker (Table 2) indicating the
quantity of DNA that gave a readable pyrogram for all the tissues tested. The sensitivity
for the frrst amplification is 5 ng; while the sensitivity for the nested PCR is 0.1-0.5 ng.
DACTJ Marker
All the DNA dilutions for the three tissue types were amplified for the DACTI
marker and the robustness was checked on a 2% agarose gel. Figure 6 shows the first
round of PCR amplification products. As noted on the gel in the first PCR round the band
intensities are stronger in all the dilutions from 0.1 ng to 50 ng suggesting high
robustness ofthis marker (Figure 6).
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Figu.re 6. Image of a 2% agarose gel showing the PCR products of all dilutions of DNA
from sperm for the DACTl marker from the first amplification. L= lOObp ladder;
N=negative control; number above each lane represents DNA quantity (ng).
For the DACTl marker all the three tissue types were analyzed, each sample with six
dilutions as described on the materials section. Interpretable data were observed in the
pyrogram from all dilutions ranging from 0.1 to 50 nanograms of DNA. Since all
dilutions from the first PCR yielded readable data, no nested PCR was performed for this
marker (Figure 7; Table 3).
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Figu.re 7. Partial sequence pyrogram showing data from 0.1 ng of DNA from sperm for
the DACTI marker.
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Table 3
DACTJ Sensitivity composite data

Sample

50 ng

10 ng

5 ng

1 ng

0.5 ng

0.1 ng

SpermIPCR

'1

'1

'1

'1

'1

'1

IIPCR

NA

NA

NA

NA

Blood I PCR

'1

'1

'1

NA

NA

NA

'1

'1

'1

NA

NA

NA

IIPCR
Buccal I PCR
IIPCR

Note.

NA

NA

'1

'1

'1

NA

NA

NA

'1

'1

NA

NA

'1
NA

'1 = indicates the concentration that gave a readable pyrogram.

NA = not analyzed.

The sensitivity results composite table for DACTl (Table 3) marker indicating the
quantity of DNA that gave a readable pyrogram for all the tissues tested. The sensitivity
for the first amplification for all tissues is 0.1 ng.
Species Specificity Study
For the species specificity study, non-human DNA samples were extracted,
bisulfite converted, and amplified with primers specific for the same three markers as in
the sensitivity portion (USP49, DDX4, and DACTl). The non-human samples used were
domestic feline blood, domestic canine blood, goat blood, cow tissue, chicken tissue,
macaque, chimpanzee, Erythrobacter (bacteria), and Pseudomonas (bacteria). Based
upon the agarose gel quantitation, the sample DNA quantities used for bisulfite
conversion ranged from approximately 60 to 500 nanograms. After PCR amplification,
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the samples were analyzed in a 2% agarose gel along with a 100 base pair DNA ladder, a
negative control, and a human positive control. The human positive control was used to
prove that the PCR reagents were working properly, incase these markers did not amplify
the non-human samples. For each of the three markers, most of the non-human samples
were amplified with approximately the right product size with varying band intensities.
The macaque and chimpanzee samples (primates), showed the most intense bands than
other samples, which was expected because of their close relatedness to humans. The rest
of the non-human samples showed varying degrees of intensity of the bands. The DDX4
marker had the faintest bands for the non-human samples than the other two markers,
except macaque and chimpanzee. The DACTl marker showed the most intense bands
than the other two markers. The USP49 marker showed bands that varied in intensity for
each sample.
DDX4 marker

All non-human samples were analyzed with a negative and human positive
control for the DDX4 marker (Figure 8). Of all the samples, cat, cow, and chicken
produced the faintest bands for this marker, and Erythrobacter bacteria did not produce
any visible product. Pseudomonas bacteria, dog, and goat also produced relatively weak
bands. The macaque, chimpanzee, and human positive control all produced relatively
intense bands, which were previously assumed to show amplification. Figure 9a shows
the actual sequence data derived from a macaque sample that matches with the human
DNA sequence while the Erythrobacter bacterial sample did not produce any readable
sequence (Figure 9b).
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Figure 8. Agarose gel image showing non-human samples for the DDX4 marker. L=IOO
bp ladder, 1) cat, 2) dog, 3) goat, 4) cow, 5) chicken, 6) macaque, 7) chimpanzee, 8)
Erythrobacter, 9) Pseudomonas, 10) human positive control, 11) negative control
A6: AGGT TAGAGYGTYGTTATAGGGGTTYGAAYGT TAGYGTTTAGG
250 · · . . · .. · · · · .. · · · · .. i
· ·l
· ·l· ·)
· ·~
· · · · · · · · · · · ·· · ·· ··· · · .. · ·
20 0

· · .. · · · · · · · . . · · · · . • · · · · · · · · · · · · · · · · · · · · · · .. · · · • · . . · ·

150 · · .. · .. · · · .. · .. • . . · · · · · · · · · · · · · · · · · · · · · · · · · · · · · .. • ·

-- --

AB: AGGT TAGAGYGTYGTTATAGG GGTTYGAAYGTTAGYGTTTAG

100 · · .. · . . · · ·

s

1S

?S

Figure 9a. Macaque sample for DDX4.

Figure 9b. Erythrobacter sample for DDX4.

Figure 9a. Partial pyrogram for the DDX4 marker, obtained from a non-human DNA
sample (macaque) that shows the same sequence as the human DNA with very high peak
heights. Figure 9b. Partial pyrogram obtained from a non-human DNA sample
(Erythrobacter bacteria) that did not produce any readable results.
USP49 marker

All non-human samples were analyzed with a negative and a human positive
control for the USP49 marker. Figure 10 shows the results of the amplification and the
resulting bands. This marker produced moderately intense bands for cat, dog, goat, cow,
macaque, chimpanzee, and human positive control samples. The chicken, Erythrobacter,
and Pseudomonas bacteria produced very faint bands. Any readable pyrogram from the
non-human samples showed the sequence comparable to the human samples. Figure 1l a
shows a partial sequence derived from a cat sample that matches the human DNA
sequence for this marker, while the chicken sample did not produce any readable results
(Figure 11 b ).
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Figure I 0. Agarose gel image showing non-human samples for the USP49 marker.
L= lOO bp ladder, 1) cat, 2) dog, 3) goat, 4) cow, 5) chicken, 6) macaque, 7) chimpanzee,
8) Erythrobacter, 9) Pseudomonas, 10) human positive control, 11) negative control.
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Figure 11 b. Chicken sample for USP49

Figure 11 a. Partial pyrogram for the USP 49 marker, obtained from a non-human DNA
sample (cat) that shows the same sequence as the human DNA. Figure I lb. Partial
pyrogram obtained from a non-human DNA sample (chicken) that did not produce any
readable results.
DACTJ marker

All non-human samples were analyzed with a negative and a human positive
control for the DACTl marker. Figure 12 shows the amplification results for all the nonhuman and human control samples. Almost every sample amplification showed strong
bands except for the dog sample. All non human sample sequences were comparable to
human sample sequence except for the dog sample that did not yield a readable sequence
data (Figure 13a, 13b).
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Figure 12. Agarose gel image showing non-human samples for the DACTl marker.
L= IOO bp ladder, 1) cat, 2) dog, 3) goat, 4) cow, 5) chicken, 6) macaque, 7) chimpanzee,
8) Erythrobacter, 9) Pseudomonas, 10) human positive control, 11) negative control.
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Figure 13a. Dog sample for DACTl .

Figure 13b. Macaque sample for DACTl.

Figure 13a. Partial pyrogram that is not sufficiently readable obtained from the dog DNA
sample. Figure 13b. Partial pyrogram showing a readable data derived from a macaque
sample.
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CHAPTERV
DISCUSSION
In regards to forensic casework, the sensitivity and species specificity of the
epigenetic markers and the technology used to test them are highly important. The
USP49, DACTl, and DDX4 markers have been deemed successful in differentiating
sperm from other biological materials. Sperm has been found to be hypomethylated
within these three loci, as opposed to other biological materials which are
hypermethylated (Kitamura et al., 2006; Lee et al., 2011). Since most forensic evidence
samples are of very limited quantities, it is crucial to determine the lowest amount of
DNA that can be used to give an acceptable methylation profile. It is also essential to
determine whether the primers for these markers are human specific or if they will also
bind to non-human DNA. The sensitivity study indicates that different DNA quantities
are necessary for different markers. Some markers are very sensitive and amplify at a
lower level of DNA concentration while others needed more DNA to generate a readable
pyrosequencing profile.
Sensitivity
The sensitivity of the USP49 and the DDX4 markers can produce adequate
profiles from at least 5 ng of DNA sample, without having to run a second round of
amplification. When demanded by circumstances where the DNA available is below 5ng,
those samples can also be analyzed using a nested round of PCR amplification. In this
study it has been determined that the second round of amplification of these two markers
produced pyrosequencing profiles that are readable with approximately 20 or more
arbitrary light units in peak heights. Samples as low as 0.1 to 0.5 nanograms of DNA
produced readable pyrosequencing data when using the nested second round of PCR
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products for sequencing. The DACTI marker produced interpretable profiles with DNA
quantities as low as 0.1 to 0.5 nanograms of template in the first round of PCR itself
without the need for a nested PCR round. The reason that DACTI primers are
performing better than USP49 and DDX4 can be due to many factors. Some markers
amplify more efficiently than others due to reasons such as, CpGs within the promoter
region or the primer binding site. If a CpG happens to be within the primer binding site,
of a target area, the primers may not bind to the target with I 00% efficiency and can
cause the primer to loop out from the sequence. During the bisulfite conversion, if a 'C'
in a CpG site is unmethylated, the ' C' is converted to a ' U', and if the 'C' is methylated it
remains as a 'C' without any changes. This results in two different target site sequences
and the primer binds to only one target efficiently. This can therefore reduce the
efficiency of the PCR reaction with lower than expected generation of PCR products.
Also, some primers may have the capability to mismatch to a wrong area of the target
DNA, thereby reducing efficiency of amplification. This can cause non-specific
amplification rather than amplification of the target sequence. Lastly, primer-dimer
formation is a common phenomenon in PCR process. This is caused by binding of one
primer to the other and causing a double stranded primer set. This reduces the availability
of primers for the PCR process and thus indirectly affecting the efficiency of the PCR
reaction.

Causes ofsample to sample variation
It was also observed that the sensitivity varied from sample to sample. This can be
caused by several reasons. Accurate DNA quantitation before bisulfite conversion is
necessary if multiple samples are used for a study. If DNA quantitation of a sample is off
to start with, this will affect the subsequent dilutions that go into the bisulfite conversion
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and what is considered Ing may not really be Ing. Quantitation can be hindered by any
extraction reagent contamination or inhibitors from the substrate. If any inhibitors that are
present in a sample are not removed, the DNA quantitation may not be accurate. Also the
bisulfite conversion can reduce the amount of DNA by up to 80-90 percent after
conversion due to random breakage of DNA. The amount of material lost during
conversion can vary from sample to sample. Vortexing of samples, handling errors, and
pipetting errors can also contribute to the differences among samples. During PCR
amplification, temperature differences of well to well in the heating block may cause
different sample PCR yield. Perhaps a well within the thermal cycler may not be
maintaining the temperature as efficiently as an adjacent well, therefore causing a
difference in the amplification efficiency. This can contribute to either the incomplete
bisulfite conversion or the sub-optimal PCR conditions.
Quality control and pyrosequencing sensitivity
There are several quality control measures that are built into the pyrosequencing
technology. One such control is a bisulfite control in the sequencing. This is the presence
of a 'C' nucleotide in the sequence. No light emission is expected at this site because
during the bisulfite conversion process, the 'C' is converted to a ' T' nucleotide and no
'C' is expected. Even if a small amount of light is captured at this site, it indicates
incomplete conversion and the quality control fails. If a sample contains areas that did not
undergo complete conversion, it can cause a warning or error message within the
pyrosequencing step. These messages, depending on how serious, can cause a whole
sample to "fail" in quality control. Other warning signs from the Pyromark software may
be from failed control injections. "Dummy" nucleotide injections are not supposed to
bind with the template, therefore no peak is expected on the pyrogram. If a peak does
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appear at this injection, it can cause the quality of the run to fail. Also, if any peak height
deviates from the reference height, it will interfere with the quality of the run. For
example, if a dispensation is supposed to produce a peak of one nucleotide incorporation,
and actually produces a peak of twice that amount, then it has deviated from the original
peak height. This can be caused by an incomplete removal of nucleotide by the
nucleotide degrading enzyme before the next dispensation. Also, if the peak heights do
not meet the specifications, the sample quality control is hindered and susceptible to error
messages.
Species Specificity
Of all the three markers studied, the DDX4 primers are more specific for humans
and higher primates. The intensity of the PCR product bands in the agarose gel is much
stronger for the macaque and chimpanzee samples compared to other non-human
samples. This suggests that the primers for the DDX4 marker are more specific for
humans and other primates compared to other non-human samples. The USP49 marker
amplifies all human and non-human samples with almost equal intensity except chicken
and the two bacterial samples used. These data suggest that there is more homology in
gene sequence between humans and non-human mammalian samples for the USP49
marker. The DACTl marker behaved close to what was observed with the USP49
marker. All PCR Amplicons showed almost equal intensity bands in the agarose gel
except for the dog. Again, the data suggests the similarity and homology of the DNA
sequence between humans and non human samples. The reason for the homology could
be that these genes may have some housekeeping functions that are essential for the life
of all living organisms or other important functions that is essential to an organism. Many
living organisms share a lot of the same physiological and biochemical mechanisms,
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some organisms sharing more mechanisms than others, due to relatedness. These
mechanisms may be controlled by a set of related genes, even if the organisms thrive in
different habitats, behave differently, or look differently than one another. Vertebrates are
more closely related to vertebrates; invertebrates are more closely related to invertebrates,
and so on. But, just because organisms are divided phylogenetically, does not mean they
do not share related sets of genes. Since these genes are needed to conduct essential life
functions among all or most organisms, they may have been conserved throughout
evolution and among all living organisms. Bergmiller, Ackerman, and Silander-Olin
(2012) concur that "the central role that essential genes play suggests they should be
highly conserved during evolution, and several comparative genomic analyses have
confirmed this hypothesis. A second implication of this pattern of conservation is that
essential genes tend to remain essential during evolution: if a gene is essential in one
organism, then orthologues of that gene are usually essential in other organisms" (p. 1).
Another study analyzed twenty tissues from chicken, frog, and pufferfish. They measured
the expression of all known genes from these tissues and compared them with ten
common mouse and human tissues. They found "evidence of conserved expression for
more than a third of unique orthologous genes" showing "strong evolutionary constraints
on tissue-specific gene expression" in tissues with limited number of specialized cell
types (Chan et al., 2009, p. 1). Several other genes that are conserved throughout the
animal kingdom have been reported in the literature (Kaul, Balamurugan, Gao-Guang, &
Matalon, 1994). For example, there has been report in the literature that regions of
ribosomal RNA (rRNA) genes are highly conserved. They have such a slow rate of
mutation that they are used as a standard for the detection of life. It is stated that there are
approximately 1500 nucleotides within the 16S/18S rRNA gene, which contains several
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regions of 15-20 nucleotide segments that are almost exactly the same within all living
organisms. This gene is said to have been conserved for over billions of years. These
genes are responsible for ribosomal catalytic activity, thus, are needed to maintain proper
life functions (Isenbarger et al., 2008). So, like the rRNA l 6S/18S gene, the genes within
this study may have some special function in an organism and positive selection may act
on these genes to conserve the gene from mutations or alterations.
Conclusion
For pyrosequencing data analysis, it has been observed that a peak height of
approximately 20 arbitrary light units provide meaningful sequence data in the
pyrograms. It can be concluded that the three specific markers studied are sensitive
enough for forensic casework. The two markers, USP49 and DDX4, produced readable
sequence data with DNA quantities as low as 5 nanograms if using the PCR products
derived from the genomic DNA, and quantities as low as 0.1 nanogram on the second
round of nested PCR amplification. The DACTl marker generated readable pyrogram
with peak heights above 20 arbitrary light units from DNA quantities as low as 0.1
nanograms and did not require a second nested amplification. Because of the robust
amplification of all three markers with small amounts of DNA, these markers can be used
for the determination of the tissue origin of a DNA sample. Of all the three markers
studied, the DDX4 primers are more specific for humans and higher primates than the
other non-human samples. The primer pairs for the other two markers, USP49 and
DACTl, have specificity not only to humans but also to other non-human samples with
the exception of bacteria, chicken and dog.
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